- Home
- KZR vs NXPL Comparison
KZR vs NXPL Comparison
Compare KZR & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- NXPL
- Stock Information
- Founded
- KZR 2015
- NXPL 1997
- Country
- KZR United States
- NXPL United States
- Employees
- KZR N/A
- NXPL N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- KZR Health Care
- NXPL Telecommunications
- Exchange
- KZR Nasdaq
- NXPL Nasdaq
- Market Cap
- KZR 29.7M
- NXPL 25.6M
- IPO Year
- KZR 2018
- NXPL N/A
- Fundamental
- Price
- KZR $6.21
- NXPL $0.70
- Analyst Decision
- KZR Hold
- NXPL
- Analyst Count
- KZR 4
- NXPL 0
- Target Price
- KZR $6.00
- NXPL N/A
- AVG Volume (30 Days)
- KZR 464.9K
- NXPL 1.8M
- Earning Date
- KZR 11-07-2025
- NXPL 11-13-2025
- Dividend Yield
- KZR N/A
- NXPL N/A
- EPS Growth
- KZR N/A
- NXPL N/A
- EPS
- KZR N/A
- NXPL N/A
- Revenue
- KZR N/A
- NXPL $58,766,000.00
- Revenue This Year
- KZR N/A
- NXPL N/A
- Revenue Next Year
- KZR N/A
- NXPL N/A
- P/E Ratio
- KZR N/A
- NXPL N/A
- Revenue Growth
- KZR N/A
- NXPL N/A
- 52 Week Low
- KZR $3.53
- NXPL $0.43
- 52 Week High
- KZR $7.65
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- KZR 67.84
- NXPL 40.05
- Support Level
- KZR $5.99
- NXPL $0.73
- Resistance Level
- KZR $6.23
- NXPL $0.82
- Average True Range (ATR)
- KZR 0.15
- NXPL 0.10
- MACD
- KZR -0.08
- NXPL -0.01
- Stochastic Oscillator
- KZR 44.44
- NXPL 7.69
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.